Legal & General Group’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,129
Closed -$15.4K 3555
2024
Q1
$15.4K Hold
3,129
﹤0.01% 3075
2023
Q4
$11.4K Sell
3,129
-385
-11% -$1.05K ﹤0.01% 3206
2023
Q3
$7.8K Buy
3,514
+511
+17% +$1.43K ﹤0.01% 3312
2023
Q2
$10.2K Hold
3,003
﹤0.01% 3315
2023
Q1
$12.1K Hold
3,003
﹤0.01% 3176
2022
Q4
$16.3K Buy
3,003
+684
+29% +$4.03K ﹤0.01% 3192
2022
Q3
$12K Sell
2,319
-1,806
-44% -$8.89K ﹤0.01% 3315
2022
Q2
$16K Buy
+4,125
New +$26.3K ﹤0.01% 3309

Legal & General Group's TGAN Position: Q2 2024 in Review

Legal & General Group sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 3,129 shares — an estimated $15.4K sold.

Legal & General Group first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $16.3K in Q4 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • Legal & General Group reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 3,129 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $15.4K.
  • Legal & General Group first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Legal & General Group's Transphorm, Inc. Common Stock position peaked at $16.3K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.